e-Article
Ofatumumab is safe and effective as front-line treatment in older patients with chronic lymphocytic leukemia and severe co-morbidities, including other malignancies
Document Type
Article
Author
Source
In Journal of Geriatric Oncology January 2020 11(1):19-23
Subject
Language
ISSN
1879-4068